Aerie Pharma (AERI) Misses Q3 EPS by 29c; Lowers Revenue Guidance
Tweet Send to a Friend
Aerie Pharma (NASDAQ: AERI) reported Q3 EPS of ($1.09), $0.29 worse than the analyst estimate of ($0.80). Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
